CATHLEEN VARLEY: Open Payments
NPI 1134169576 · FLUSHING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,186 in 52 payments from 10 companies in 2025. Trend: 2023 $1,928 · 2024 $7,075 · 2025 $1,186
Food & beverage: $1,186
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 25 | $347 |
| Abbott Laboratories | 10 | $222 |
| E.R. Squibb & Sons, L.L.C. | 2 | $147 |
| Novo Nordisk Inc | 6 | $143 |
| Alnylam Pharmaceuticals Inc. | 1 | $135 |
| AstraZeneca Pharmaceuticals LP | 4 | $88 |
| Kestra Medical Technology Services, Inc. | 1 | $39 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| SCPHARMACEUTICALS INC. | 1 | $22 |
| Boston Scientific Corporation | 1 | $18 |
Products named: LEQVIO, CARDIOMEMS, CAMZYOS, ONPATTRO, Wegovy, Ozempic, WAINUA, Assure WCD.
Industry payments across NY — which companies pay providers there.
